The Excretion of Cisplatin after Hyperthermic Intrathoracic Chemotherapy

The Excretion of Cisplatin after Hyperthermic Intrathoracic Chemotherapy

Hyperthermic intrathoracic chemotherapy (HITOC) is an additional intraoperative treatment option within the multimodality therapy of pleural malignancies. A chemotherapy perfusion with high-dose cisplatin is performed over a period of 60 min after surgical cytoreduction to improve local tumour contr...

Full description

Bibliographic Details
Main Authors:	Christopher Larisch, Till Markowiak, Michael Ried, Dennis Nowak, Hans-Stefan Hofmann, Stefan Rakete
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Cancers
Subjects:	hyperthermic intrathoracic chemotherapy HITOC excretion of cisplatin malignant pleural mesothelioma mesothelioma thymoma
Online Access:	https://www.mdpi.com/2072-6694/15/19/4872

Similar Items

Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study
by: Michael Ried, et al.
Published: (2021-09-01)

Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
by: Tommi Järvinen, et al.
Published: (2021-07-01)

Outcome after cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy in patients with secondary pleural metastases
by: Mohamed Hassan, et al.
Published: (2023-11-01)

Anaesthetic management of extra-pleural pneumonectomy and hyperthermic intrathoracic chemotherapy procedure
by: Jalaja Koppa Ramegowda, et al.
Published: (2015-01-01)

Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis
by: Ioannis Karampinis, et al.
Published: (2022-04-01)

Evaluation of Surgical Therapy in Advanced Thymic Tumors
by: Till Markowiak, et al.
Published: (2021-09-01)

Comparison of video-assisted pleurectomy/decortication surgery plus hyperthermic intrathoracic chemotherapy with VATS talc pleurodesis for the treatment of malignant pleural mesothelioma: A pilot study
by: Marcello Migliore, et al.
Published: (2023-06-01)

Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial
by: Lili Liu, et al.
Published: (2023-12-01)

Extended pleurectomy/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesotheliomaCentral MessagePerspective
by: Kenichi Okubo, MD, PhD, et al.
Published: (2023-12-01)

A case report of hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) for malignant peritoneal mesothelioma
by: Hanjian Liu, et al.
Published: (2023-12-01)

Diffuse Peritoneal Malignant Mesothelioma Presenting with Abnormal Uterine Bleeding: Case Report
by: Ivana Rizzuto, et al.
Published: (2022-03-01)

Ectopic thymoma presenting as a giant intrathoracic mass: A Case Report
by: Takenaka Tomoyoshi, et al.
Published: (2012-07-01)

Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma
by: Agnes Y. Choi, et al.
Published: (2022-05-01)

An Autopsied Case of Malignant Sarcomatoid Pleural Mesothelioma in Which Chest Pain Developed Several Months Earlier without Abnormality on Imaging
by: Daizo Yaguchi, et al.
Published: (2015-10-01)

Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma
by: Mégane Willems, et al.
Published: (2023-03-01)

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
by: Dearbhaile Catherine Collins, et al.
Published: (2020-12-01)

Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
by: Federica Pezzuto, et al.
Published: (2021-07-01)

A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma
by: Jamil MO, et al.
Published: (2017-06-01)

Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment
by: Vittorio Aprile, et al.
Published: (2021-08-01)

Interobserver Agreement in Histopathological Subtyping of Malignant Pleural Mesotheliomas
by: Mona MLIKA, et al.
Published: (2021-01-01)

Malignant Mesothelioma in Cappadocia: Data from Eight Regional Hospitals
by: İpek Pınar Aral, et al.
Published: (2020-09-01)

Incidence of pleural mesothelioma in a community exposed to fibres with fluoro-edenitic composition in Biancavilla (Sicily, Italy)
by: Caterina Bruno, et al.
Published: (2014-06-01)

Secondary Malignant Peritoneal Mesothelioma of the Greater Omentum after Therapy for Primary Pleural Mesothelioma
by: Andreas Gutzeit, et al.
Published: (2013-04-01)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
by: Jacopo Moro, et al.
Published: (2022-12-01)

Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States
by: Lucia Calthorpe, et al.
Published: (2022-12-01)

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort
by: Vahan Kepenekian, et al.
Published: (2021-01-01)

Desmoid-type fibromatosis in the setting of malignant peritoneal mesothelioma: a case report of two rare diseases
by: Stephanie N. Gregory, et al.
Published: (2022-09-01)

Malignant mediastinal mesothelioma treated with anlotinib: a case report and review of the literature
by: Yishi Zhang, et al.
Published: (2023-05-01)

Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma
by: Iacopo Gesmundo, et al.
Published: (2022-09-01)

Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary
by: Nicholas K. Larsen, et al.
Published: (2020-11-01)

Management of Pleural Effusion Secondary to Malignant Mesothelioma
by: Valeria Musso, et al.
Published: (2021-09-01)

Unsymmetric Cisplatin-Based Pt(IV) Conjugates Containing a PARP-1 Inhibitor Pharmacophore Tested on Malignant Pleural Mesothelioma Cell Lines
by: Elisabetta Gabano, et al.
Published: (2021-08-01)

Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatment
by: Senk Barbara, et al.
Published: (2019-03-01)

Extensive surgical resections for rare pleural neoplasms: a single-center experience with a yolk sac tumor and synovial sarcoma
by: Tom Vandaele, et al.
Published: (2024-04-01)

New Insights in Pleural Mesothelioma Classification Update: Diagnostic Traps and Prognostic Implications
by: Maria Giovanna Mastromarino, et al.
Published: (2022-11-01)

Assessment of the value of mesothelin in differentiating between different pleural malignancies by different interventional modalities
by: Mona M Ahmed, et al.
Published: (2022-01-01)

Analysis of the Effect of Radiotherapy on Malignant Pleural Mesothelioma when Given on Adjuvant or Palliative Basis
by: Abdel RAHMAN M, et al.
Published: (2010-01-01)

Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01)

Malignant mesothelioma
by: Suzanne Alkul, et al.
Published: (2016-04-01)

Malignant Mesothelioma Presenting After Resolution of a Seemingly Benign Asbestos Related Pleural Effusion
by: Avinash Aujayeb
Published: (2019-11-01)